Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...

Scientists from National Taiwan University (NTU) and Linkou Chang Gung Memorial Hospital (CGMH) have developed a ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

How does the brain choose between fight, flight, or freeze? Tulane University scientists have discovered the neural pathways ...

The way to a person’s brain is through their stomach. That’s the conclusion of a growing body of scientific studies that look ...

Artelo Biosciences, Inc. (NASDAQ: ARTL) is drawing increased attention following its expansion into the $16.3 billion ...

Biotech specialist Aptamer Group says it is edging closer to commercial validation of its synthetic binder technology.

One of the wireless electromyography modules (bottom left) that is used to transmit data collected from the wearer. © 2026 ...

Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature Neuroscience demonstrating that Deep Brain Stimulation (DBS) achieves therapeutic ...

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...

This milestone launches dapansutrile into Phase 2 clinical development for neurological conditions, expanding upon ongoing trials with dapansutrile in rheumatologic diseases (Phas ...